Back to News
Market Impact: 0.35
What 10x Genomics (TXG) Said on Its Q3 Earnings Call
Source: marketbeat.com
Corporate EarningsCorporate Guidance & OutlookTechnology & InnovationCompany Fundamentals
10x Genomics raised its full-year revenue outlook after reporting modest third-quarter growth. The company also increased its shipment target for its new Atera spatial biology platform; the article provides no figures for the outlook or target changes.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
TXG0.65
More News
- Further turmoil could be in store for tech stocks. What to watch in the week ahead
- Tech stock rout, driven by US AI fears, continues in Asian trading
- Asian Markets Tally Losses From Worsening Global Rout
- AI’s Grip on Financial Markets Was Never Clearer on the Way Down
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- AI stocks hammered by midterm shock as data center buildout becomes a 'war of attrition'